-
181“…Efforts to increase the epidemiologic data on the pneumococcal vaccination should be taken. To increase the vaccination rate, it would be necessary to raise the awareness and priority of the pneumococcal vaccination; a feasible way could be the combination of the seasonal flu vaccination campaign with a campaign for pneumococcal vaccination.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
182por Le Meur, Jean-Baptiste, Lefebvre, Brigitte, Proulx, Jean-François, Déry, Serge, Pépin, Jacques, De Wals, Philippe“…More effective pneumococcal vaccines are needed to eliminate geographic disparities in IPD risk.…”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
183por Liguori, Giorgio, Liguori, Giorgio, Parlato, Antonino, Parlato, Antonino, Zamparelli, Alessandro Sanduzzi, Zamparelli, Alessandro Sanduzzi, Belfiore, Patrizia, Belfiore, Patrizia, Gallé, Francesca, Gallé, Francesca, Di Onofrio, Valeria, Di Onofrio, Valeria, Riganti, Carla, Riganti, Carla, Zamparelli, Bruno, Zamparelli, Bruno, Horizon Scanning (SIHHS), Società Italiana di Health, Horizon Scanning (SIHHS), Società Italiana di Health“…The economic evaluation of pneumococcal vaccine for adult groups represents an essential instrument to support health policies. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
184por Jump, Robin L., Banks, Richard, Wilson, Brigid, Montpetite, Michelle M., Carter, Rebecca, Phillips, Susan, Perez, Federico“…Within 180 days, 38 of 76 patients (50%) received a pneumococcal vaccination. A virtual clinic may optimize vaccinations among high-risk patients.…”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
185“…The 23-valent pneumococcal vaccine is recommended for adults over 65 years of age and younger adults with certain medical conditions. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
186por Wyllie, Anne L., Wijmenga-Monsuur, Alienke J., van Houten, Marlies A., Bosch, Astrid A. T. M., Groot, James A., van Engelsdorp Gastelaars, Jody, Bruin, Jacob P., Bogaert, Debby, Rots, Nynke Y., Sanders, Elisabeth A. M., Trzciński, KrzysztofEnlace del recurso
Publicado 2016
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
187“…The aim of this study was to compare the immunologic response to a prime-boost immunization strategy combining the 13-valent conjugate pneumococcal vaccine (PCV13) with the 23-valent polysaccharide pneumococcal vaccine (PPSV23) versus the PPSV23 alone in HIV-infected adults. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
188por Dyda, Amalie, Karki, Surendra, Hayen, Andrew, MacIntyre, C. Raina, Menzies, Robert, Banks, Emily, Kaldor, John M., Liu, Bette“…BACKGROUND: In the absence of an adult vaccination register, coverage estimates for influenza and pneumococcal vaccination come from surveys and other data sources. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
189por Bock, Allison, Chintamaneni, Kathan, Rein, Lisa, Frazer, Tifany, Kayastha, Gyan, MacKinney, Theodore“…Despite the ready availability of effective pneumococcal vaccines (PNV), vaccine coverage rates remain suboptimal globally. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
190
-
191por Gentile, Angela, Bakir, Julia, Lucion, Maria Florencia, Juarez, Maria Del Valle, Rapaport, Solana, Areso, Maria SoledadEnlace del recurso
Publicado 2018
Enlace del recurso
Online Artículo Texto -
192“…We used mortality due to malignant neoplasm and heart disease as control groups and employed a DID design with an assumed parallel mortality trend between pneumonia and control group mortality since 2013 to estimate the causal effect of pneumococcal vaccination from 2014. RESULTS: Our estimation based on malignant neoplasm and heart disease as controls indicated that the reduced pneumonia mortality in 2017 owing to pneumococcal vaccination was as large as 41.9 (33.2, 50.6) and 31.2 (23.8, 38.6) per 100,000 individuals, respectively. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
193por Chan, Win-Yan, Entwisle, Claire, Ercoli, Giuseppe, Ramos-Sevillano, Elise, McIlgorm, Ann, Cecchini, Paola, Bailey, Christopher, Lam, Oliver, Whiting, Gail, Green, Nicola, Goldblatt, David, Wheeler, Jun X., Brown, Jeremy S.Enlace del recurso
Publicado 2019
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
194
-
195“…We model the impact of pneumococcal vaccination using interrupted time series analysis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
196“…BACKGROUND: Pneumococcal vaccination for infants was introduced to the mandatory National Immunization Program (NIP) of Korea in May 2014. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
197por Albrich, Werner C., Rassouli, Frank, Waldeck, Frederike, Berger, Christoph, Baty, Florent“…The effects of pneumococcal vaccine indications decreased with older age. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
198por Frank, Oliver, De Oliveira Bernardo, Carla, González-Chica, David Alejandro, Macartney, Kristine, Menzies, Robert, Stocks, Nigel“…In Australia, pneumococcal vaccine is provided free to all adults aged ≥65 years and Indigenous people aged 15–65 years, and is subsidized for non-Indigenous adults <65 years of age with risk factors. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
199por Jirru, Ermias, Lee, Stefi, Harris, Rebecca, Yang, Jianjun, Cho, Soo Jung, Stout-Delgado, Heather“…The purpose of our current study was to investigate the role of immune imprinting by influenza on pneumococcal vaccine effectiveness during Streptococcus pneumoniae infection in the aged murine lung. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
200por Gatwood, Justin, Chiu, Chi-Yang, Shuvo, Sohul A, Ramachandran, Sujith, Hohmeier, Kenneth, Hagemann, Tracy“…To address this gap, this study assessed the potential influence of select social determinants on uptake of and time to pneumococcal vaccination among a high-risk, insured US population. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto